glp 1 medication for sleep apnea GLP-1 Zepbound Is Approved As First Drug Therapeutic Potential of Glucagon-like Peptide-1

This blog covers a recent Renegade Research Roundtable, two studies reporting on the effects of GLP-1 agonists on people with mast cell activation syndrome (MCAS) and intracranial hypertension, and two major GLP-1 long-COVID trials getting underway

Over the last few years, Recent surveys show that about one in every eight adults in the United States or 12% are currently taking a GLP-1 medication like Wegovy or Zepbound for weight loss or treatment of a chronic condition

The peptides versus SARMs comparison highlights this distinction further for researchers weighing metabolic peptides against other compound categories entirely

Unlike GLP-1 and GIP, glucagon has a stronger role in how the body uses stored energy

Beard, E